American Capital, Ltd. (NasdaqGS:ACAS) along with management of Cambridge Major Laboratories acquired Cambridge Major Laboratories, Inc. from Arlington Capital Partners II, L.P. of Arlington Capital Partners, Tangshan Jidong Products and Materials Trading Group Co., Ltd and Palladon Ventures Ltd. (TSXV:PLL) for approximately $210 million in a management buyout on December 27, 2012. American Capital's investment took the form of debt and preferred and common equity for paying off the purchase price. For the year 2011, Cambridge Major reported revenues of $100 million. Brian Scanlan, President and Chief Executive of Cambridge Major, will retain leadership even as ownership changes hands. Jefferies & Company, Inc. acted as financial advisor for Cambridge Major Laboratories. Gibson, Dunn & Crutcher LLP acted as legal advisor to Arlington Capital Partners. Akash D. Sethi of Patton Boggs LLP acted as legal advisor for American Capital.

American Capital, Ltd. (NasdaqGS:ACAS) along with management of Cambridge Major Laboratories completed the acquisition of Cambridge Major Laboratories, Inc. from Arlington Capital Partners II, L.P. of Arlington Capital Partners, Tangshan Jidong Products and Materials Trading Group Co., Ltd and Palladon Ventures Ltd. (TSXV:PLL) in a management buyout on December 27, 2012.